Published in J Pharm Pharmacol on April 01, 1985
Evaluation of EpiDerm full thickness-300 (EFT-300) as an in vitro model for skin irritation: studies on aliphatic hydrocarbons. Toxicol In Vitro (2009) 0.77
Percutaneous absorption of aromatic amines in rubber industry workers: impact of impaired skin and skin barrier creams. Occup Environ Med (2006) 0.76
Mechanism of enhanced dermal permeation of 4-cyanophenol and methyl paraben from saturated aqueous solutions containing both solutes. Skin Pharmacol Physiol (2010) 0.75
The effect of temperature and ionic strength on the apparent Ca-affinity of EGTA and the analogous Ca-chelators BAPTA and dibromo-BAPTA. Biochim Biophys Acta (1987) 2.68
Doxycycline therapy for leptospirosis. Ann Intern Med (1984) 2.29
Mouse Dll3: a novel divergent Delta gene which may complement the function of other Delta homologues during early pattern formation in the mouse embryo. Development (1997) 2.03
A rapid Percoll gradient procedure for isolation of synaptosomes directly from an S1 fraction: homogeneity and morphology of subcellular fractions. Brain Res (1988) 1.70
Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement. Pharm Res (1991) 1.46
Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci (2008) 1.43
The current distribution of CD4+ T-lymphocyte counts among adults in the United States with human immunodeficiency virus infections: estimates based on the experience of the U.S. Army. U.S. Army Retrovirus Research Group. J Acquir Immune Defic Syndr (1990) 1.42
Effects of freezing on human skin permeability. J Pharm Pharmacol (1984) 1.27
The non-peptide NK1 receptor antagonist, (+/-)-CP-96,345, produces antinociceptive and anti-oedema effects in the rat. Br J Pharmacol (1992) 1.27
Absorption of some glycol ethers through human skin in vitro. Environ Health Perspect (1984) 1.15
Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm (2000) 1.15
Evidence of endocrine involvement early in the course of human immunodeficiency virus infection. J Clin Endocrinol Metab (1990) 1.08
Different regional effects of voluntary exercise on the mechanical and electrical properties of rat ventricular myocytes. J Physiol (2002) 1.05
Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil. J Pharm Pharmacol (1994) 1.05
The 'Iceman': molecular structure of 5200-year-old skin characterised by Raman spectroscopy and electron microscopy. Biochim Biophys Acta (1995) 1.03
Skin absorption enhancers. Crit Rev Ther Drug Carrier Syst (1992) 1.02
Treatment of arsenical refractory Rhodesian sleeping sickness in Kenya. Ann Trop Med Parasitol (1989) 1.01
Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies. J Pharm Pharmacol (1999) 1.01
Ultra-slow voltage-dependent inactivation of the calcium current in guinea-pig and ferret ventricular myocytes. Pflugers Arch (1994) 1.00
A method for reversible permeabilization of isolated rat ventricular myocytes. Exp Physiol (1998) 0.99
Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. I. Infinite dose technique. J Invest Dermatol (1988) 0.99
Ca2+ and Na+ in rat myocytes showing different force-frequency relationships. Am J Physiol (1991) 0.98
Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro. J Pharm Pharmacol (2001) 0.98
In vitro absorption of some o-phthalate diesters through human and rat skin. Environ Health Perspect (1987) 0.98
A direct negative inotropic effect of acetylcholine on rat ventricular myocytes. Am J Physiol (1993) 0.97
Turnover of carbon, nitrogen, and sulfur in bovine longissimus dorsi and psoas major muscles: Implications for isotopic authentication of meat. J Anim Sci (2008) 0.96
Increased sensitivity to the antinociceptive activity of (+/-)-baclofen in an animal model of chronic neuropathic, but not chronic inflammatory hyperalgesia. Neuropharmacology (1994) 0.96
Negative inotropic effects of tumour necrosis factor-alpha and interleukin-1beta are ameliorated by alfentanil in rat ventricular myocytes. Br J Pharmacol (2007) 0.94
Terpene penetration enhancers in propylene glycol/water co-solvent systems: effectiveness and mechanism of action. J Pharm Pharmacol (1995) 0.93
Bioavailability of topical steroids. Dermatologica (1976) 0.93
Wide-angle X-ray diffraction of human stratum corneum: effects of hydration and terpene enhancer treatment. J Pharm Pharmacol (1994) 0.93
Stress incontinence and the physiotherapist. Physiotherapy (1983) 0.93
Vasoconstrictor activities of some novel synthetic steroids in alcoholic solution. J Invest Dermatol (1975) 0.92
The role of inward Na(+)-Ca2+ exchange current in the ferret ventricular action potential. J Physiol (1997) 0.92
Urinary incontinence of non-neurogenic origin. Physiotherapy (1973) 0.92
Retinopathy in childhood dermatomyositis. Am J Ophthalmol (1973) 0.90
Skin hydration and possible shunt route penetration in controlled estradiol delivery from ultradeformable and standard liposomes. J Pharm Pharmacol (2001) 0.90
Vasoconstrictor activities and bio-availabilities of seven proprietary corticosteroid creams assessed using a non-occluded multiple dosage regimen; clinical implications. Br J Dermatol (1977) 0.89
Comparative bio-availability of proprietary topical corticosteroid preparations; vasoconstrictor assays on thirty creams and gels. Br J Dermatol (1974) 0.88
Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int J Pharm (2004) 0.88
Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. Int J Pharm (2000) 0.87
Grading corneal ulcers. Ann Ophthalmol (1975) 0.87
Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human skin. J Pharm Pharmacol (1987) 0.87
Prevalence of serum antibody to the type-specific glycopeptidolipid antigens of Mycobacterium avium in human immunodeficiency virus-positive and -negative individuals. J Clin Microbiol (1991) 0.86
Effects of isoflurane, sevoflurane, and halothane on myofilament Ca2+ sensitivity and sarcoplasmic reticulum Ca2+ release in rat ventricular myocytes. Anesthesiology (2000) 0.86
GR94839, a kappa-opioid agonist with limited access to the central nervous system, has antinociceptive activity. Br J Pharmacol (1992) 0.86
Effects of halothane on the transient outward K(+) current in rat ventricular myocytes. Br J Pharmacol (2000) 0.86
Palosuran inhibits binding to primate UT receptors in cell membranes but demonstrates differential activity in intact cells and vascular tissues. Br J Pharmacol (2008) 0.86
Enhancement by terpenes of 5-fluorouracil permeation through the stratum corneum: model solvent approach. J Pharm Pharmacol (1998) 0.85
The isolation of dimethyl sulfoxide soluble components from human epidermal preparations: a possible mechanism of action of dimethyl sulfoxide in effecting percutaneous migration phenomena. J Invest Dermatol (1971) 0.85
Limitations of hairless mouse skin as a model for in vitro permeation studies through human skin: hydration damage. J Invest Dermatol (1988) 0.85
Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen. J Control Release (1998) 0.85
A list of vertebrate cardiac ionic currents nomenclature, properties, function and cloned equivalents. Cardiovasc Res (1996) 0.85
Mechanistic study into the enhanced transdermal permeation of a model beta-blocker, propranolol, by fatty acids: a melting point depression effect. Int J Pharm (2001) 0.84
Non-ionic surfactants and gastric mucosal transport of paraquat. J Pharm Pharmacol (1981) 0.84
Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin. J Invest Dermatol (1988) 0.84
Regional effects of voluntary exercise on cell size and contraction-frequency responses in rat cardiac myocytes. J Exp Biol (2001) 0.84
Penetration enhancers for human skin: mode of action of 2-pyrrolidone and dimethylformamide on partition and diffusion of model compounds water, n-alcohols, and caffeine. J Invest Dermatol (1983) 0.83
Neuron death in the substantia nigra of weaver mouse occurs late in development and is not apoptotic. J Neurosci (1996) 0.83
Subcutaneous phycomycosis. Trop Geogr Med (1994) 0.82
Developmental toxicity studies in Crl:CD (SD) rats following inhalation exposure to trichloroethylene and perchloroethylene. Birth Defects Res B Dev Reprod Toxicol (2006) 0.82
Transmural variations in gene expression of stretch-modulated proteins in the rat left ventricle. Pflugers Arch (2007) 0.82
Absorption through human skin of ibuprofen and flurbiprofen; effect of dose variation, deposited drug films, occlusion and the penetration enhancer N-methyl-2-pyrrolidone. J Pharm Pharmacol (1985) 0.82
Shed snake skin and hairless mouse skin as model membranes for human skin during permeation studies. J Invest Dermatol (1990) 0.81
Effects of trichloroethylene (TCE) on an in vitro chick atrioventricular canal culture. Toxicol Sci (2000) 0.81
Neuropeptide changes persist in spinal cord despite resolving hyperalgesia in a rat model of mononeuropathy. Brain Res (1996) 0.81
Thermally induced molecular disorder in human stratum corneum lipids compared with a model phospholipid system; FT-Raman spectroscopy. Spectrochim Acta A Mol Biomol Spectrosc (1998) 0.80
The placebo response to white soft paraffin-propylene glycol in the skin blanching test. Br J Dermatol (1973) 0.80
Bioavailability and activity of topical corticosteroids from a novel drug delivery system, the aerosol quick-break foam. J Pharm Sci (1977) 0.80
The control of oil-in-water emulsion consistency using mixed emulsifiers. J Pharm Pharmacol (1969) 0.80
Quantitative analysis of Na+-Ca2+ exchanger expression in guinea-pig heart. Eur J Biochem (2000) 0.80
Concentration-dependent inotropic effects of halothane, isoflurane and sevoflurane on rat ventricular myocytes. Br J Anaesth (1999) 0.79
The role of Na(+)-Ca2+ exchange current in electrical restitution in ferret ventricular cells. J Physiol (1997) 0.79
Oral amoxycillin, an alternative treatment for neurosyphilis. Genitourin Med (1985) 0.79
Drug interaction and location in liposomes: correlation with polar surface areas. Int J Pharm (2005) 0.79
Halothane and sevoflurane inhibit Na/Ca exchange current in rat ventricular myocytes. Br J Anaesth (2005) 0.79
Correlation of thermodynamic activity and vapour diffusion through human skin for the model compound, benzyl alcohol. J Pharm Pharmacol (1985) 0.79
Solubilization of hydrocortisone, dexamethasone, testosterone and progesterone by long-chain polyoxyethylene surfactants. J Pharm Pharmacol (1976) 0.78
A critical comparison of some Raman spectroscopic techniques for studies of human stratum corneum. Pharm Res (1993) 0.78
A comparison of techniques for the measurement of transepidermal water loss. Arch Dermatol Res (1982) 0.78
Effects of halothane on action potential configuration in sub-endocardial and sub-epicardial myocytes from normotensive and hypertensive rat left ventricle. Br J Anaesth (2003) 0.78
Comparison of ultra-slow, voltage-dependent inactivation of the cardiac L-type Ca2+ channel with Ca2+ or Ba2+ as the charge carrier in ferret ventricular myocytes. Exp Physiol (1996) 0.78
Correlation of viscoelastic functions for pharmaceutical semisolids: comparison of creep and oscillatory tests for oil-in-water creams stabilized by mixed emulsifiers. J Pharm Sci (1973) 0.78
Effect of melting point of chiral terpenes on human stratum corneum uptake. Int J Pharm (2001) 0.78
Transdermal permeation modulation by cyclodextrins: a mechanistic study. Pharm Dev Technol (1998) 0.77
Transient and sustained changes in myofilament sensitivity to Ca2+ contribute to the inotropic effects of sevoflurane in rat ventricle. Br J Anaesth (2004) 0.77
The contribution of mitochondrial calcium ion exchange to relaxation of tension in cardiac muscle. Mol Cell Biochem (1989) 0.77
Effects of halothane on contraction and intracellular calcium in ventricular myocytes from streptozotocin-induced diabetic rats. Br J Anaesth (2004) 0.77
Citrate decreases contraction and Ca current in cardiac muscle independent of its buffering action. Am J Physiol (1991) 0.77
Bioavailability and activity of betamethasone 17-benzoate in gel and cream formulations: comparison with proprietary topical corticosteroid preparations in the vasoconstrictor assay. Curr Ther Res Clin Exp (1974) 0.77
The effect of temperature on the rate-dependent decrease of the rat ventricular calcium current. Exp Physiol (1998) 0.77
Halothane inhibits contraction and action potential duration to a greater extent in subendocardial than subepicardial myocytes from the rat left ventricle. Anesthesiology (2001) 0.77
Effects of the Anemonia sulcata toxin (ATX II) on intracellular sodium and contractility in rat and guinea-pig myocardium. Pharmacol Toxicol (1994) 0.77
Changes in contraction, cytosolic Ca2+ and pH during metabolic inhibition and upon restoration of mitochondrial respiration in rat ventricular myocytes. Exp Physiol (1998) 0.76
Pre treatment with MK-801, a non-competitive NMDA antagonist, prevents development of mechanical hyperalgesia in a rat model of chronic neuropathy, but not in a model of chronic inflammation. Neurosci Lett (1994) 0.76